Fabio Mauro Giambò

Dr. Fabio Mauro Giambò

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
CFCaterina Formica
Caterina Formica
Lilla BonannoLilla Bonanno
Lilla Bonanno
FGFabio Mauro Giambò
Fabio Mauro Giambò
GMGiuseppa Maresca
Giuseppa Maresca
DLDesiree Latella
Desiree Latella
Viviana Lo BuonoViviana Lo Buono
Viviana Lo Buono
Alzheimer’s disease (AD) is the most common form of neurodegenerative disorder. The prodromal phase of AD is mild cognitive impairment (MCI). The capacity to predict the transitional phase from MCI to AD represents a challenge for the scientific community. The adoption of artificial intelligence (AI) is useful for diagnostic, predictive analysis starting from the clinical epidemiology of neurodegenerative disorders. We propose a Machine Learning Model (MLM) where the algorithms were trained on a set of neuropsychological, neurophysiological, and clinical data to predict the diagnosis of cognitive decline in both MCI and AD patients. Methods: We built a dataset with clinical and neuropsychological data of 4848 patients, of which 2156 had a diagnosis of AD, and 2684 of MCI, for the Machine Learning Model, and 60 patients were enrolled for the test dataset. We trained an ML algorithm using RoboMate software based on the training dataset, and then calculated its accuracy using the test dataset. Results: The Receiver Operating Characteristic (ROC) analysis revealed that diagnostic accuracy was 86%, with an appropriate cutoff value of 1.5; sensitivity was 72%; and specificity reached a value of 91% for clinical data prediction with MMSE. Conclusion: This method may support clinicians to provide a second opinion concerning high prognostic power in the progression of cognitive impairment. The MLM used in this study is based on big data that were confirmed in enrolled patients and given a credibility about the presence of determinant risk factors also supported by a cognitive test score.

26 June 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
MPMaria Pagano
Maria Pagano
FCFrancesco Corallo
Francesco Corallo
AAANNA ANSELMO
ANNA ANSELMO
FGFabio Mauro Giambò
Fabio Mauro Giambò
GMGiuseppe Micali
Giuseppe Micali
ICIrene Cappadona
Irene Cappadona
Heart failure (HF) is a growing epidemic, affecting millions of people worldwide, and is a major cause of mortality, morbidity, and impaired quality of life. Traditional cardiac rehabilitation is a valuable approach to the physical and quality-of-life recovery of patients with cardiovascular disease. The innovative approach of remote monitoring through telemedicine offers a solution based on modern technologies, enabling continuous collection of health data outside the hospital environment. Remote monitoring devices present challenges that could adversely affect patient adherence, resulting in the risk of dropout. By applying a cognitive-behavioral model, we aim to identify the antecedents of dropout behavior among patients adhering to traditional cardiac rehabilitation programs and remote monitoring in order to improve the latter. Our study was conducted from October 2023 to January 2024. In the first stage, we used data from literature consultation. Subsequently, data were collected from the direct experience of 49 health workers related to both remote monitoring and traditional treatment, recruited from the authors’ workplace. Results indicate that patients with cardiovascular disease tend to abandon remote monitoring programs more frequently than traditional cardiac rehabilitation therapies. It is critical to design approaches that take these barriers into account to improve adherence and patient satisfaction. This analysis identified specific antecedents to address, helping to improve current monitoring models. This is crucial to promote care continuity and to achieve self-management by patients in the future.

Verified
Journal Article
Open access
PDF file
FCFrancesco Corallo
Francesco Corallo
GMGiuseppa Maresca
Giuseppa Maresca
CFCaterina Formica
Caterina Formica
Lilla BonannoLilla Bonanno
Lilla Bonanno
ABAlessia Bramanti
Alessia Bramanti
Viviana Lo BuonoViviana Lo Buono
Viviana Lo Buono
Severe acquired brain injury (SABI) is a major global public health problem and a source of disability. A major contributor to disability after SABI is limited access to multidisciplinary rehabilitation, despite evidence of sustained functional gains, improved quality of life, increased return to work, and reduced need for long-term care. Twelve patients with a diagnosis of SABI were enrolled and equally divided into two groups: experimental and control. Patients in both groups underwent intensive neurorehabilitation according to the severity of their disabilities (motor, psycho-cognitive, and sensory deficits). However, in the experimental group, the treatment was performed by using a humanoid robot. At baseline, the two groups differed significantly only in Severe Impairment Battery (SIB) scores. Results showed that the experimental treatment had a higher effect than the traditional one on quality of life and mood. In conclusion, this pilot study provides evidence of the possible effects of relational and cognitive stimulation in more severely brain-injured patients.

Verified
Journal Article
Open access
PDF file
CSCarmela Settimo
Carmela Settimo
Maria Cristina De ColaMaria Cristina De Cola
Maria Cristina De Cola
EPErica Pironti
Erica Pironti
RMRosalia Muratore
Rosalia Muratore
FGFabio Mauro Giambò
Fabio Mauro Giambò
FCFrancesca Cucinotta
Francesca Cucinotta
Global developmental delay (GDD) is a complex disorder that requires multimodal treatment involving different developmental skills. The objective of this single-blind, randomized, controlled pilot study is to evaluate the feasibility and effectiveness of conventional rehabilitation programs integrated with the BTs-Nirvana virtual reality system. Patients with GDD aged 12 to 66 months were enrolled and treated for a 48-session cycle. Patients were randomized into two groups, (1) conventional treatment and (2) conventional treatment supplemented with the use of BTs-Nirvana, in a 1:1 ratio. Before and after treatments, areas of global development were tested with the Griffiths-III Mental Developmental Scale and the clinical indicator of global improvement were measured with the Clinical Global Impressions-Improvement (CGI-I). Feasibility was confirmed by the high retention rate. The experimental group presented a significantly improvement in General Quotient (GQ) after treatment (GQ, p = 0.02), and the effect of the two treatments was significantly different in both the GQ (t =2.44; p = 0.02) and the Foundations of Learning subscale (t =3.66; p < 0.01). The overall improvement was also confirmed by the CGI-I (p = 0.03). According to these preliminary data, virtual reality can be considered a useful complementary tool to boost the effectiveness of conventional therapy in children with GDD.

10 July 2024 in Healthcare
Verified
Journal Article
Open access
PDF file
GMGiuseppe Micali
Giuseppe Micali
FCFrancesco Corallo
Francesco Corallo
MPMaria Pagano
Maria Pagano
FGFabio Mauro Giambò
Fabio Mauro Giambò
ADAntonio Duca
Antonio Duca
ICIrene Cappadona
Irene Cappadona
Cardiovascular and neurological diseases are a major cause of mortality and morbidity worldwide. Such diseases require careful monitoring to effectively manage their progression. Artificial intelligence (AI) offers valuable tools for this purpose through its ability to analyse data and identify predictive patterns. This review evaluated the application of AI in cardiac and neurological diseases for their clinical impact on the general population. We reviewed studies on the application of AI in the neurological and cardiological fields. Our search was performed on the PubMed, Web of Science, Embase and Cochrane library databases. Of the initial 5862 studies, 23 studies met the inclusion criteria. The studies showed that the most commonly used algorithms in these clinical fields are Random Forest and Artificial Neural Network, followed by logistic regression and Support-Vector Machines. In addition, an ECG-AI algorithm based on convolutional neural networks has been developed and has been widely used in several studies for the detection of atrial fibrillation with good accuracy. AI has great potential to support physicians in interpretation, diagnosis, risk assessment and disease management.

1 May 2025 in Digital Health
Verified
Journal Article
Open access
Maria Grazia MaggioMaria Grazia Maggio
Maria Grazia Maggio
Amelia RizzoAmelia Rizzo
Amelia Rizzo
ABAlessandra Benenati
Alessandra Benenati
FGFabio Mauro Giambò
Fabio Mauro Giambò
ACAntonino Cannavò
Antonino Cannavò
Rocco Salvatore Salvatore CalabròRocco Salvatore Salvatore Calabrò
Rocco Salvatore Salvatore Calabrò
Objective: Parkinson's disease (PD) is a progressive neurodegenerative disorder that not only impairs motor functions but also may lead to significant cognitive decline, greatly affecting the quality of life for both patients and their caregivers. This study aims to evaluate the feasibility and potential effectiveness of cognitive tele-rehabilitation (TR) plus virtual reality (VR), compared to traditional home-based rehabilitation methods, focusing on cognitive outcomes, quality of life, usability, and the impact on caregiver strain in patients with PD. Methods: In this pilot randomized controlled trial, 20 PD patients and their primary caregivers were randomly assigned to either a control group (CG) receiving traditional cognitive training or an experimental group (EG) undergoing cognitive TR using a VR rehabilitation system, with assessments conducted before and after the 8-week intervention. Results: TR was rated as highly usable (System Usability Scale mean score: 84.3 ± 9.5). Post-intervention analyses showed significant improvements in global cognitive functioning (Montreal Cognitive Assessment (MoCA): p = 0.002) and quality of life (Parkinson's Disease Questionnaire (PDQ)-8: p = 0.002) in the EG. The CG also showed improvements in MoCA ( p = 0.008) and PDQ-8 ( p = 0.016), although to a lesser extent than the EG. A reduction in caregiver burden was observed in both groups but did not reach statistical significance. Analysis of Δ scores revealed a significantly greater MoCA improvement in the EG compared to the CG ( p = 0.019). Statistically significant differences were found between the groups in the Family Strain Questionnaire and PDQ-8 Δ scores. Conclusion: These findings suggest that cognitive TR, particularly when integrated with VR, might be useful in improving cognitive function and quality of life in PD patients and could play a key role in future PD management strategies, potentially easing the burden on caregivers.